Since p53 functions are known to be modulated in a cell-type specific manner (reviewed in ref. [27]), we compared the HSPA8, MAD1 and CRYZ transcript levels, post-adriamycin treatment, in two non-small cell lung carcinoma cell lines viz. This evidence concerns the gene TP53 and non-small cell lung carcinoma.